Is the pharmaceutical industry ready for the digital revolution?

Digital transformation is now affecting every industry. It's not only revolutionizing how they operate but also driving innovation and streamlining processes. The pharmaceutical industry is no exception.

As Laura Marozsan, Marketing Specialist at Thermo Fisher Scientific, puts it, “Developing and manufacturing pharmaceutical products is a data-intensive process that presents significant opportunities for digital transformation .” With growing patient needs and the seemingly endless amounts of information being collected, the digital revolution in pharmaceutical software is not only a long-awaited innovation, but a necessity.

Pharma 4.0: The Future of the Pharmaceutical Industry

Pharma 4.0 can be described similarly to Industry 4.0. According to Alasdair Gilchrist, it is the convergence of people, laboratory management software, and data in the industrial process to increase quality, productivity, and profits by harnessing the power of advanced data analytics—which could also be called LIMS Pharma.

The ever-expanding market not only forces the pharmaceutical industry to remain competitive but also to comply with stringent regulations. Pharma 4.0 technology enables real-time process monitoring to detect and predict non-compliance as quickly as possible.

Furthermore, LIMS Pharma 4.0 streamlines processes and accelerates product development by standardizing and digitizing operations. With the introduction of Big Data solutions, vast amounts of data can be easily accessed, categorized, and analyzed. This invaluable revolution ensures efficient information sharing.

Pharma 4.0 represents a significant improvement over automated process control (APC) strategies because it not only provides error detection but also more accurate error prediction.

Faster test results

Thanks to the digital revolution, R&D teams can conduct research faster, thus accelerating the process of introducing new products. Time is money, especially when health is at stake. According to Laura Marozsan, "one technology that is being recognized for its ability to accelerate research and development (R&D) is artificial intelligence, including its subfields of machine learning and deep learning . "

This isn't the only advantage of machine learning. As Marozsan notes, "in the case of rare diseases, artificial intelligence can shorten the time it takes to make an accurate diagnosis and plan treatment . "

When collaborating with R&D teams and innovation partners, quick access to data is invaluable. Furthermore, it's crucial to leverage it to better design experiments.

The digital revolution focuses on data architecture and its compliance with the FAIR Data Principles. These principles ensure that data is discoverable, accessible, interoperable, and reusable.

Additionally, faster access to data enables better and easier collaboration between the pharmaceutical industry, regulators, academia and healthcare providers, while process virtualization streamlines the development process.

Greater productivity

As demand for medical products continues to grow, so does the need to streamline testing. To improve laboratory efficiency, it's essential to support technicians and increase their productivity with pharmaceutical software.

It's easier said than done. However, digital solutions make this task much easier – tools like augmented reality glasses not only improve the quality of work but also accelerate its pace. Holo4Labs is an example of such a solution, combining Microsoft® HoloLens technology and Thermo Scientific™ SampleManager LIMS™ software .

As Paweł Gawkowski says, "One of the many benefits of a virtual interface is improving laboratory productivity, not only in terms of data automation but also in streamlining workflow, processes, and collaboration. It also allows laboratory technicians to perform some processes remotely or partially remotely, thus speeding up their work and reducing the number of people needed on-site."

As Laura Marozsan emphasizes, "a key element facilitating the use of AI systems is that all research data is easily accessible in a centralized location." To achieve this, data management systems such as LIMS are being implemented. The system streamlines the process of sharing and analyzing data by organizing and collecting it.

This solution makes data easily accessible to authorized users, and significantly reduces the risk of data loss. Eliminating manual data entry also simplifies the search process and ensures quick access to the database.

Risk management

The growing need to use laboratory management software and other digital systems to reduce risk is another factor that has revolutionized the pharmaceutical industry.

Digital management systems minimize the risk of data loss and mishandling. They also ensure consistency by eliminating errors associated with manual transcription and offline processes, as well as incompatibility between systems.

The pharmaceutical industry is subject to strict regulations and must meet a wide variety of legal requirements, so a reliable and standardized system is essential.

The future of the pharmaceutical industry

With LIMS Pharma, digital transformation means improving safety, quality and productivity in the pharmaceutical industry.

The software will perfectly cope with growing patient needs, endless demands, and massive amounts of data. Thanks to intelligent analytical solutions, including LIMS, laboratory productivity will not only gradually increase but also modernize.

If you want to talk about the details, let's talk - we will tell you about the benefits of LIMS for your laboratory.